Quetiapine in the treatment of schizophrenia and related disorders

Quetiapine was developed in 1985 by scientists at AstraZeneca (formerly Zeneca) Pharmaceuticals. It received official US Food and Drug Administration approval in September 1997 and approval in Germany in 2000. Since then, quetiapine has been used in the treatment of severe mental illness in approxim...

Descripción completa

Detalles Bibliográficos
Autores principales: Riedel, Michael, Müller, Norbert, Strassnig, Martin, Spellmann, Ilja, Severus, Emanuel, Möller, Hans-Jürgen
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654633/
https://www.ncbi.nlm.nih.gov/pubmed/19300555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654633/
https://www.ncbi.nlm.nih.gov/pubmed/19300555

Ejemplares similares